Shares of health insurance provider Elevance Health (NYSE:EVH)
fell 3.2% in the morning session after the company reported third-quarter results showing that rising medical costs squeezed profits, despite an increase in revenue. Although operating revenue grew 12.4% year on year to $50.71 billion, the company's profitability declined. The operating gain in its Health Benefits segment reportedly fell sharply to $0.6 billion from $1.6 billion in the same period a year ago, driven by higher medical expenses. The company's benefit expense ratio—which measures how much of its premium revenue is spent on medical care—increased, with the rise attributed to cost trends in its Medicare business. As a result of these pressures, quarterly adjusted earnings per share dropped to $6.03 from $8.37 in the previous year's quarter, overshadowing the fact that both revenue and earnings beat Wall Street's expectations.
Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, while optimism across earnings kept industrial stocks powering higher and pushed the Dow Jones to fresh record highs.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session.
Elevance Health (ELV) beat Q3 earnings and revenue estimates, driven by strategic acquisitions and premium growth. The stock rose on the strong results.
Health insurance provider Elevance Health (NYSE:EVH) announced better-than-expected revenue in Q3 CY2025, with sales up 12.4% year on year to $50.71 billion. Its non-GAAP profit of $6.03 per share was 22% above analysts’ consensus estimates.
Health insurance provider Elevance Health (NYSE:EVH)
will be announcing earnings results this Tuesday before market open. Here’s what you need to know.
Washington D.C., October 6, 2025 – The American labor market appears to have hit a significant speed bump, with Moody's Analytics reporting "essentially no job growth" for the U.S. in September 2025. This concerning assessment comes at a critical juncture for the economy, compounded by an ongoing federal government
New York, NY – October 3, 2025 – While market reports today, October 3, 2025, show UnitedHealth Group (NYSE: UNH) as a top performer in the Dow Jones Industrial Average, with shares gaining approximately 1.5% and extending a five-day winning streak, a closer examination reveals a more complex narrative. Despite this
Louisville, KY – October 3, 2025 – Humana Inc. (NYSE: HUM) witnessed a significant surge in its stock price today, jumping an impressive 11.9% in early trading. This substantial gain has positioned the managed care giant as a top performer in the financial markets, reflecting robust investor confidence and potentially signaling
Another historic session is unfolding on Wall Street, where every major index surged to new records by midday trading on Friday, even as Washington's shutdown dragged into its third day.
In the volatile landscape of the US stock market, the actions of corporate insiders often serve as a potent barometer for future performance and underlying sentiment. As of late September 2025, a conspicuous trend has emerged: a significant tilt towards insider selling over buying, painting a picture of caution from
